The global Pediatric Drugs and Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Drugs and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type Diphtheria Influenza Hepatitis Pneumococcal Diseases Meningococcal Diseases Mumps Others Segment by Application Newborn Infant Child The Pediatric Drugs and Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the Pediatric Drugs and Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions. By Company Merck & Co., Inc. (USA) Abbott Laboratories (USA) Amgen, Inc. (USA) Eli Lilly and Company (USA) F. Hoffmann-La Roche Ltd (Switzerland) Genentech, Inc. (USA) GlaxoSmithKline plc. (UK) Janssen Biologics B.V. (USA) Actelion Pharmaceuticals AstraZeneca Plc. (UK) Boehringer Ingelheim GmbH (Germany) Bristol-Myers Squibb Company (USA) Allergan, Inc. (USA) Novartis AG (Switzerland) Novo Nordisk A/S (Denmark) Pfizer, Inc. (USA) Sanofi S.A (France) Shionogi Inc. (USA) Takeda
1 Pediatric Drugs and Vaccines Market Overview 1.1 Pediatric Drugs and Vaccines Product Scope 1.2 Pediatric Drugs and Vaccines Segment by Type 1.2.1 Global Pediatric Drugs and Vaccines Sales by Type (2016 & 2021 & 2027) 1.2.2 Diphtheria 1.2.3 Influenza 1.2.4 Hepatitis 1.2.5 Pneumococcal Diseases 1.2.6 Meningococcal Diseases 1